National Institutes of Health: Hemolysis trials

The registry lists 10 Hemolysis studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 1Phase 3 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism DisordersRecruitingNCT06092346
• Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood DisordersCompletedNCT01316796Phase 1
• Probiotic Ingestion and Isoagglutinin TitersCompletedNCT00891787Phase 1
• Evaluation of Toxicity From Stem Cell TransplantCompletedNCT00631787
• Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary HypertensionCompletedNCT00352430Phase 1
• Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid PhenotypesTerminatedNCT00102245
• Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeTerminatedNCT00004465Phase 3
• Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedNCT00004381Phase 2
• Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
• Treatment of Autoimmune Thrombocytopenia (AITP)CompletedNCT00001630Phase 1